{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:12:10Z","timestamp":1791493930609,"version":"4.3.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Mulago-KCCA project","award":["None"],"award-info":[{"award-number":["None"]}]},{"name":"RASHOTS","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>There is an increasing burden of non-communicable disease globally. Tenofovir disoproxil fumarate (TDF) is the most commonly prescribed antiretroviral drug globally. Studies show that patients receiving TDF are more prone to renal dysfunction at some point in time during treatment. Evaluation of kidney function is not routinely done in most HIV public clinics. Identification of renal dysfunction is key in resource constrained settings because managing patients with end stage renal disease is costly.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Method<\/jats:title>\n<jats:p>This was a cross-sectional study conducted at an outpatient clinic in 2018 involving patients on TDF for at least 6\u2009months who were 18\u2009years or older. Patients with documented kidney disease and pregnancy were excluded. Estimated glomerular filtration rate (eGFR) was calculated using the CKD-Epi formula. Renal dysfunction was defined as any of the following; either eGFR&lt;\u200960\u2009mL\/min\/1.73m<jats:sup>2<\/jats:sup>,or proteinuria of \u22652<jats:sup>+<\/jats:sup> on urine dipstick, glycosuria with normal blood glucose. Electrolyte abnormalities were also documented.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We enrolled 278 participants. One hundred sixty nine (60.8%) were females, majority 234(84.2%) were\u2009&lt;\u200950\u2009years old, 205 (73.74%) were in WHO stage 1, most participants 271(97.5%) in addition to TDF were receiving lamivudine\/efavirenz. The median age was 37(IQR 29\u201345) years; median duration on ART was 36 (IQR 24\u201360) months. The prevalence of renal dysfunction was 2.52% (7\/278). Most noted electrolyte abnormality was hypocalcaemia (15.44%).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The prevalence of renal dysfunction was low though some participants had hypocalcaemia. Screening for kidney disease should be done in symptomatic HIV infected patients on TDF.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12882-020-01873-y","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T09:02:42Z","timestamp":1592816562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prevalence of renal dysfunction among HIV infected patients receiving Tenofovir at Mulago: a cross-sectional study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7101-4042","authenticated-orcid":false,"given":"Louis","family":"Nyende","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kalyesubula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Sekasanvu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Byakika-Kibwika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"issue":"5","key":"1873_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000244","volume":"7","author":"MD Holmes","year":"2010","unstructured":"Holmes MD, Dalal S, Volmink J, Adebamowo CA, Njelekela M, Fawzi WW, et al. Non-communicable diseases in sub-Saharan Africa: the case for cohort studies. PLoS Med. 2010;7(5):e1000244.","journal-title":"PLoS Med"},{"key":"1873_CR2","first-page":"1","volume":"2","author":"TN Haregu","year":"2012","unstructured":"Haregu TN, Oldenburg B, Sestwe G, Elliott J, Nanayakkara V. Epidemiology of comorbidity of HIV\/AIDS and non-communicable diseases in developing countries: a systematic review. J Global Health Care Syst. 2012;2:1.","journal-title":"J Global Health Care Syst"},{"issue":"3","key":"1873_CR3","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1016\/S2214-109X(14)70002-6","volume":"2","author":"JW Stanifer","year":"2014","unstructured":"Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(3):e174\u2013e81.","journal-title":"Lancet Glob Health"},{"issue":"2","key":"1873_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/kisup.2013.4","volume":"3","author":"S Naicker","year":"2013","unstructured":"Naicker S. End-stage renal disease in sub-Saharan Africa. Kidney Int Suppl. 2013;3(2):161\u20133.","journal-title":"Kidney Int Suppl"},{"key":"1873_CR5","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/ckj\/sfw104","volume":"9","author":"P Campos","year":"2016","unstructured":"Campos P, Ortiz A, Soto K. HIV and kidney diseases: 35 years of history and consequences. Clin Kidney J. 2016;9:772 sfw104.","journal-title":"Clin Kidney J"},{"issue":"8","key":"1873_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrneph.2015.85","volume":"11","author":"OJ Wouters","year":"2015","unstructured":"Wouters OJ, O'donoghue DJ, Ritchie J, Kanavos PG, Narva AS. Early chronic kidney disease: diagnosis, management and models of care. Nat Rev Nephrol. 2015;11(8):491.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1873_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1590\/S0101-28002011000100013","volume":"33","author":"MG Bastos","year":"2011","unstructured":"Bastos MG, Kirsztajn GM. Chronic kidney disease: importance of early diagnosis, immediate referral and structured interdisciplinary approach to improve outcomes in patients not yet on dialysis. Jornal brasileiro de nefrologia. 2011;33(1):93\u2013108.","journal-title":"Jornal brasileiro de nefrologia"},{"key":"1873_CR8","volume-title":"90\u201390-90: an ambitious treatment target to help end the AIDS epidemic","author":"HIV\/AIDS JUNPo","year":"2014","unstructured":"HIV\/AIDS JUNPo. 90\u201390-90: an ambitious treatment target to help end the AIDS epidemic. Geneva: UNAIDS; 2014."},{"key":"1873_CR9","volume-title":"Prevent HIV, test and treat all-WHO support for country impact. Progress report 2016","author":"Organization WH","year":"2017","unstructured":"Organization WH. Prevent HIV, test and treat all-WHO support for country impact. Progress report 2016. 2017."},{"issue":"3","key":"1873_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3947\/ic.2017.49.3.194","volume":"49","author":"EJ Kim","year":"2017","unstructured":"Kim EJ, Ahn JY, Kim YJ, Wie S-H, Park DW, Song J-Y, et al. The prevalence and risk factors of renal insufficiency among Korean HIV-infected patients: the Korea HIV\/AIDS cohort study. Infect Chemother. 2017;49(3):194\u2013205.","journal-title":"Infect Chemother"},{"issue":"9709","key":"1873_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0140-6736(09)62067-5","volume":"375","author":"DART","year":"2010","unstructured":"DART. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet. 2010;375(9709):123.","journal-title":"Lancet"},{"issue":"6","key":"1873_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1089\/apc.2009.0326","volume":"24","author":"N Crum-Cianflone","year":"2010","unstructured":"Crum-Cianflone N, Ganesan A, Teneza-Mora N, Riddle M, Medina S, Barahona I, et al. Prevalence and factors associated with renal dysfunction among HIV-infected patients. AIDS Patient Care STDs. 2010;24(6):353\u201360.","journal-title":"AIDS Patient Care STDs"},{"issue":"1","key":"1873_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.kint.2015.12.059","volume":"90","author":"C Osafo","year":"2016","unstructured":"Osafo C, Raji YR, Olanrewaju T, Mamven M, Arogundade F, Ajayi S, et al. Genomic approaches to the burden of kidney disease in sub-Saharan Africa: the human heredity and health in Africa (H3Africa) kidney disease research network. Kidney Int. 2016;90(1):2\u20135.","journal-title":"Kidney Int"},{"key":"1873_CR14","first-page":"e195","volume":"1","author":"M SCarPino","year":"2015","unstructured":"SCarPino M, Santoro M, PelliCan\u00f2 G. HIV infection and kidney disease: literature review. Infect Dis Trop Med. 2015;1:e195.","journal-title":"Infect Dis Trop Med"},{"issue":"1","key":"1873_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12882-015-0035-3","volume":"16","author":"P Odongo","year":"2015","unstructured":"Odongo P, Wanyama R, Obol JH, Apiyo P, Byakika-Kibwika P. Impaired renal function and associated risk factors in newly diagnosed HIV-infected adults in Gulu hospital, Northern Uganda. BMC Nephrol. 2015;16(1):43.","journal-title":"BMC Nephrol"},{"key":"1873_CR16","first-page":"1","volume":"8","author":"E Wantakisha","year":"2017","unstructured":"Wantakisha E, Chongwe G, Munkombwe D, Michelo C. Renal dysfunction among HIV-infected patients on tenofovir-based antiretroviral therapy at Ronald Ross Hospital in Zambia. J AIDS Clin Res. 2017;8:1.","journal-title":"J AIDS Clin Res"},{"issue":"23","key":"1873_CR17","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1056\/NEJMra054415","volume":"354","author":"LA Stevens","year":"2006","unstructured":"Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function\u2014measured and estimated glomerular filtration rate. N Engl J Med. 2006;354(23):2473\u201383.","journal-title":"N Engl J Med"},{"issue":"3","key":"1873_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092717","volume":"9","author":"SK Gupta","year":"2014","unstructured":"Gupta SK, Anderson AM, Ebrahimi R, Fralich T, Graham H, Scharen-Guivel V, et al. Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients. PLoS One. 2014;9(3):e92717.","journal-title":"PLoS One"},{"issue":"2","key":"1873_CR19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/ndt\/gfm836","volume":"23","author":"CP Emem","year":"2007","unstructured":"Emem CP, Arogundade F, Sanusi A, Adelusola K, Wokoma F, Akinsola A. Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrology Dialysis Transplantation. 2007;23(2):741\u20136.","journal-title":"Nephrology Dialysis Transplantation"},{"key":"1873_CR20","volume-title":"Brief report :Trimethoprim induced hyperkalemia in a patient with AIDS","author":"J Michael","year":"1993","unstructured":"Michael J, Choi PCF, Patnaik A, Kleyman TR. Brief report :Trimethoprim induced hyperkalemia in a patient with AIDS; 1993."},{"issue":"6","key":"1873_CR21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/QAD.0b013e3283262a64","volume":"23","author":"P Labarga","year":"2009","unstructured":"Labarga P, Barreiro P, Martin-Carbonero L, Rodriguez-Novoa S, Solera C, Medrano J, et al. Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. Aids. 2009;23(6):689\u201396.","journal-title":"Aids."},{"issue":"8","key":"1873_CR22","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1086\/656412","volume":"51","author":"GA McComsey","year":"2010","unstructured":"McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS, et al. Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis. 2010;51(8):937\u201346.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"1873_CR23","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1681\/ASN.2012080857","volume":"24","author":"J Tourret","year":"2013","unstructured":"Tourret J, Deray G, Isnard-Bagnis C. Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword? J Am Soc Nephrol. 2013;24(10):1519\u201327.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"1873_CR24","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1056\/NEJM199303113281006","volume":"328","author":"MJ Choi","year":"1993","unstructured":"Choi MJ, Fernandez PC, Patnaik A, Coupaye-Gerard B, D'andrea D, Szerlip H, et al. Trimethoprim-induced hyperkalemia in a patient with AIDS. New England Journal of Medicine. 1993;328(10):703\u20136.","journal-title":"New England Journal of Medicine"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01873-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-01873-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01873-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T23:43:33Z","timestamp":1624319013000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-01873-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1873"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-01873-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"3 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by Department of Medicine of Makerere University College of health sciences, school of medicine, research & ethics committee (SOMREC) and the Mulago hospital ethics committee. All participants provided written informed consent at enrollment. The consent process was administered in both English and local language determined by the preference of the participant.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"\u201cNot applicable\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"232"}}